About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [761 citations: 1–100 of 721 articles]

Articles published in Prostate Cancer have been cited 761 times. The following is a list of the 721 articles that have cited the articles published in Prostate Cancer.

  • H. Xu, P.D. Bai, M.B. Hu, S.H. Mao, W.H. Zhu, J.M. Hu, S.H. Liu, T. Yang, J.Y. Hou, Y. Hu, Q. Ding, and H.W. Jiang, “Infragradación de la biopsia de próstata respecto a la pieza de prostatectomía la población china: nomogramas actualizados,” Actas Urológicas Españolas, 2016. View at Publisher · View at Google Scholar
  • A. Guijarro, L. Reguero, V. Hernández, J.M. de la Morena, E. De la Peña, B. López, B. Fernández, C. Parrilla, E. Pérez-Fernández, I. Alemany, and C. Llorente, “Diagnostic yield and complications of extended lymphadenectomy versus limited lymphadenectomy combined with radical prostatectomy,” Actas Urológicas Españolas (English Edition), 2016. View at Publisher · View at Google Scholar
  • Ayobami Ajayi, Wei-Ting Hwang, Neha Vapiwala, Mark Rosen, Christina H. Chapman, Stefan Both, Meera Shah, Xingmei Wang, Atu Agawu, Peter Gabriel, John Christodouleas, Zelig Tochner, and Curtiland Deville, “Disparities in Staging Prostate Magnetic Resonance Imaging Utilization for Non-Metastatic Prostate Cancer Patients Undergoing Definitive Radiotherapy,” Advances in Radiation Oncology, 2016. View at Publisher · View at Google Scholar
  • Axel S. Merseburger, and Marie C. Hupe, “An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer,” Advances in Therapy, 2016. View at Publisher · View at Google Scholar
  • Aifen Li, Jieyu Xing, Li Li, Changhua Zhou, Bin Dong, Ping He, Qing Li, and Zhong Wang, “A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells,” AMB Express, vol. 6, no. 1, 2016. View at Publisher · View at Google Scholar
  • Yu-Dong Zhang, Chen-Jiang Wu, Mei-Ling Bao, Hai Li, Xu Yan, Xi-Sheng Liu, and Hai-Bin Shi, “New RESOLVE-Based Diffusional Kurtosis Imaging in MRI-Visible Prostate Cancer: Effect of Reduced b Value on Image Quality and Diagnostic Effectiveness,” American Journal of Roentgenology, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Minyong Kang, Jong Jin Oh, Sangchul Lee, Sung Kyu Hong, Sang Eun Lee, and Seok-Soo Byun, “Perineural Invasion and Lymphovascular Invasion are Associated with Increased Risk of Biochemical Recurrence in Patients Undergoing Radical Prostatectomy,” Annals of Surgical Oncology, vol. 23, no. 8, pp. 2699–2706, 2016. View at Publisher · View at Google Scholar
  • Francisco D.C. Guerra Liberal, Adriana Alexandre S. Tavares, and João Manuel R.S. Tavares, “Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153,” Applied Radiation and Isotopes, 2016. View at Publisher · View at Google Scholar
  • Yuejiao Huang, Chun Cheng, Chong Zhang, Yonghui Zhang, Miaomiao Chen, Douglas W. Strand, and Ming Jiang, “Advances in prostate cancer research models: from transgenic mice to tumor xenografting models,” Asian Journal of Urology, 2016. View at Publisher · View at Google Scholar
  • Jin Xu, and Yun Qiu, “Role of androgen receptor splice variants in prostate cancer metastasis,” Asian Journal of Urology, 2016. View at Publisher · View at Google Scholar
  • William L. Harryman, James P. Hinton, Cynthia P. Rubenstein, Parminder Singh, Raymond B. Nagle, Sarah J. Parker, Beatrice S. Knudsen, and Anne E. Cress, “The Cohesive Metastasis Phenotype in Human Prostate Cancer,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2016. View at Publisher · View at Google Scholar
  • Lawrence G. Lum, Archana Thakur, Sri Vidya Kondadasula, Zaid Al-Kadhimi, Abhinav Deol, Elyse N. Tomaszewski, Hiroshi Yano, Dana L. Schalk, Lois Ayash, Jeffrey A. Zonder, Joseph P. Uberti, Muneer H. Abidi, and Voravit Ratanatharathorn, “Targeting Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity,” Biology of Blood and Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • Domenica Rea, Vitale del Vecchio, Giuseppe Palma, Antonio Barbieri, Michela Falco, Antonio Luciano, Davide De Biase, Sisto Perdonà, Gaetano Facchini, and Claudio Arra, “Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX,” BioMed Research International, vol. 2016, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Ruifeng Fan, Haidong Yao, Xia Zhao, Changyu Cao, Tianshu Yang, Yilin Luan, Ziwei Zhang, and Shiwen Xu, “Gene expression of selenoproteins can be regulated by selenoprotein K silencing in chicken myoblasts,” BioMetals, 2016. View at Publisher · View at Google Scholar
  • Tine M. Storebjerg, Søren Høyer, Pia Kirkegaard, Flemming Bro, Torben F. Ørntoft, Michael Borre, and Karina D. Sørensen, “ Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness ,” BJU International, 2016. View at Publisher · View at Google Scholar
  • Kasper D. Berg, Frederik B. Thomsen, Camilla Nerstrøm, Martin A. Røder, Peter Iversen, Birgitte G. Toft, Ben Vainer, and Klaus Brasso, “The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis,” BJU International, vol. 117, no. 6, pp. 883–889, 2016. View at Publisher · View at Google Scholar
  • Jin Tae Kwak, Stephen M. Hewitt, André Alexander Kajdacsy-Balla, Saurabh Sinha, and Rohit Bhargava, “Automated prostate tissue referencing for cancer detection and diagnosis,” BMC Bioinformatics, vol. 17, no. 1, 2016. View at Publisher · View at Google Scholar
  • Kristina Stuopelyte, Kristina Daniunaite, Arnas Bakavicius, Juozas R Lazutka, Feliksas Jankevicius, and Sonata Jarmalaite, “The utility of urine-circulating miRNAs for detection of prostate cancer,” British Journal of Cancer, 2016. View at Publisher · View at Google Scholar
  • Carol E. DeSantis, Rebecca L. Siegel, Ann Goding Sauer, Kimberly D. Miller, Stacey A. Fedewa, Kassandra I. Alcaraz, and Ahmedin Jemal, “Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities,” CA: A Cancer Journal for Clinicians, 2016. View at Publisher · View at Google Scholar
  • Ilinca Georgescu, Robert J. Gooding, R. Christopher Doiron, Andrew Day, Shamini Selvarajah, Chris Davidson, David M. Berman, and Paul C. Park, “Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genes,” Cancer & Metabolism, vol. 4, no. 1, 2016. View at Publisher · View at Google Scholar
  • Lindsey A. Torre, Rebecca L. Siegel, Elizabeth M. Ward, and Ahmedin Jemal, “Global Cancer Incidence and Mortality Rates and Trends-An Update,” Cancer Epidemiology Biomarkers & Prevention, vol. 25, no. 1, pp. 16–27, 2016. View at Publisher · View at Google Scholar
  • Richard M. Hoffman, Angela L. W. Meisner, Wadih Arap, Marc Barry, Satyan K. Shah, Steven B. Zeliadt, and Charles L. Wiggins, “Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012,” Cancer Epidemiology Biomarkers & Prevention, vol. 25, no. 2, pp. 259–263, 2016. View at Publisher · View at Google Scholar
  • Emma H. Allott, Lauren E. Howard, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, and Stephen J. Freedland, “Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database,” Cancer Epidemiology Biomarkers & Prevention, vol. 25, no. 3, pp. 547–554, 2016. View at Publisher · View at Google Scholar
  • Ailin Zhang, Jiawei Zhang, Arja Kaipainen, Jared M. Lucas, and Hong Yang, “Long non-coding RNA: A newly deciphered “code” in prostate cancer,” Cancer Letters, 2016. View at Publisher · View at Google Scholar
  • Eileen Brantley, Mariana A. Callero, Damian E. Berardi, Petreena Campbell, Leah Rowland, Dain Zylstra, Louisa Amis, Michael Yee, Marina Simian, Laura Todaro, Andrea Loaiza-Perez, and Ubaldo Soto, “AhR ligand aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity,” Cancer Letters, 2016. View at Publisher · View at Google Scholar
  • Alexandru Mihai Nicolae, Niranjan Venugopal, and Ananth Ravi, “Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers,” Cancer Nanotechnology, vol. 7, no. 1, 2016. View at Publisher · View at Google Scholar
  • Claudia Peitzsch, Monica Cojoc, Linda Hein, Ina Kurth, Katrin Maebert, Franziska Trautmann, Barbara Klink, Evelin Schroeck, Manfred P. Wirth, Mechthild Krause, Eduard A. Stakhovsky, GennadyD. Telegeev, Vladimir Novotny, Marieta Toma, Michael Muders, Gustavo B. Baretton, Fiona M. Frame, Norman J. Maitland, Michael Baumann, and Anna Dubrovska, “An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells,” Cancer Research, vol. 76, no. 9, pp. 2637–2651, 2016. View at Publisher · View at Google Scholar
  • A J Browne, A Göbel, S Thiele, L C Hofbauer, M Rauner, and T D Rachner, “p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells,” Cell Death and Disease, vol. 7, no. 2, pp. e2119, 2016. View at Publisher · View at Google Scholar
  • Wan Low, and Nahrizul Kadri, “Computational Analysis of Enhanced Circulating Tumour Cell (CTC) Separation in a Microfluidic System with an Integrated Dielectrophoretic-Magnetophorectic (DEP-MAP) Technique,” Chemosensors, vol. 4, no. 3, pp. 14, 2016. View at Publisher · View at Google Scholar
  • Christina Bluemel, and Ken Herrmann, “New technologies in radioguided surgery in complex anatomic areas,” Clinical and Translational Imaging, 2016. View at Publisher · View at Google Scholar
  • Sergi Vidal-Sicart, and Renato A. Valdés Olmos, “Synergism of SPECT/CT and portable gamma cameras for intraoperative sentinel lymph node biopsy in melanoma, breast cancer, and other malignancies,” Clinical and Translational Imaging, 2016. View at Publisher · View at Google Scholar
  • O. R. Brouwer, H. G. van der Poel, R. F. Bevers, E. J. van Gennep, and S. Horenblas, “Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies?,” Clinical and Translational Imaging, 2016. View at Publisher · View at Google Scholar
  • Renata Zelic, Valentina Fiano, Daniela Zugna, Chiara Grasso, Luisa Delsedime, Lorenzo Daniele, Diego Galliano, Andreas Pettersson, Anna Gillio-Tos, Franco Merletti, and Lorenzo Richiardi, “Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebi,” Clinical Cancer Research, vol. 22, no. 4, pp. 984–992, 2016. View at Publisher · View at Google Scholar
  • Adam Kowalewski, Łukasz Szylberg, Anna Skórczewska, and Andrzej Marszałek, “Diagnostic difficulties with atrophy, atypical adenomatous hyperplasia (AAH) and atypical small acinar proliferation (ASAP). A Systematic Review of Current Literature,” Clinical Genitourinary Cancer, 2016. View at Publisher · View at Google Scholar
  • John M. Watkins, Darrion L. Mitchell, J. Kyle Russo, Sarah L. Mott, Chad R. Tracy, Mark C. Smith, and John M. Buatti, “Gleason Score ≤ 6 Prostate Cancer at Radical Prostatectomy: Does a High-Risk Setting Truly Exist? A Recursive Partitioning Analysis,” Clinical Genitourinary Cancer, 2016. View at Publisher · View at Google Scholar
  • Negar Pouyanfar, Ahmad Monabbati, Alireza Amin Sharifi, and Mehdi Dianatpour, “Expression Levels of MMP9 and PIWIL2 in Prostate Cancer: a Case-Control Study,” Clinical Laboratory, vol. 62, no. 4, pp. 651–657, 2016. View at Publisher · View at Google Scholar
  • Jean Piechowski, “Trophoblastic-like transdifferentiation: A key to oncogenesis,” Critical Reviews in Oncology/Hematology, 2016. View at Publisher · View at Google Scholar
  • Maria J. Alvarez-Cubero, Fernando Vazquez-Alonso, Ignacio Puche-Sanz, F. Gabriel Ortega, M. Martin-Prieto, Jose L. Garcia-Puche, Manrique Pascual-Geler, Jose A. Lorente, Jose M. Cozar-Olmo, and Maria J. Serrano, “Dormant Circulating Tumor Cells in Prostate Cancer: Therapeutic, Clinical and Biological Implications,” Current Drug Targets, vol. 17, no. 6, pp. 693–701, 2016. View at Publisher · View at Google Scholar
  • Maria Raffaella Ambrosio, Luigi Pirtoli, and Maria Teresa del Vecchio, “Emerging Targets for Prostate Adenocarcinoma Therapy: How Molecular Biology May Drive Towards a More Tailored Approach?,” Current Drug Targets, vol. 17, no. 3, pp. 266–275, 2016. View at Publisher · View at Google Scholar
  • Mandi M. Hopkins, and Kathryn E. Meier, “Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk,” Current Nutrition Reports, 2016. View at Publisher · View at Google Scholar
  • Eugene A Zhukovsky, Richard J Morse, and Marcela V Maus, “Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection,” Current Opinion in Immunology, vol. 40, pp. 24–35, 2016. View at Publisher · View at Google Scholar
  • Lisa M. Cordes, James L. Gulley, and Ravi A. Madan, “The evolving role of immunotherapy in prostate cancer,” Current Opinion in Oncology, vol. 28, no. 3, pp. 232–240, 2016. View at Publisher · View at Google Scholar
  • Manish K. Thakur, and Ulka Vaishampayan, “Multifaceted and personalized therapy of advanced prostate cancer,” Current Opinion in Oncology, vol. 28, no. 3, pp. 222–231, 2016. View at Publisher · View at Google Scholar
  • Marlon Perera, Todd Manning, Antonio Finelli, and Nathan Lawrentschuk, “Management of men with previous negative prostate biopsy,” Current Opinion in Urology, vol. 26, no. 5, pp. 481–487, 2016. View at Publisher · View at Google Scholar
  • Christina J. Turner, and Claire M. Edwards, “The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease,” Current Osteoporosis Reports, 2016. View at Publisher · View at Google Scholar
  • Ester Fernandez-Salas, Shaomeng Wang, and Arul M Chinnaiyan, “Role of BET proteins in castration-resistant prostate cancer,” Drug Discovery Today: Technologies, 2016. View at Publisher · View at Google Scholar
  • Ayorinde Adehin, Oluseye Oladotun Bolaji, and Martin A. Kennedy, “Polymorphisms in CYP2C8 and CYP3A5 genes in the Nigerian population,” Drug Metabolism and Pharmacokinetics, 2016. View at Publisher · View at Google Scholar
  • Skerdi Haviari, Pierre Cassier, Cédric Dananché, Monique Hulin, Olivier Dauwalder, Olivier Rouvière, Xavier Bertrand, Michel Perraud, Thomas Bénet, and Philippe Vanhems, “ Outbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi Infections after Prostate Biopsies, France, 2014 ,” Emerging Infectious Diseases, vol. 22, no. 8, 2016. View at Publisher · View at Google Scholar
  • Luigia Florimonte, Luca Dellavedova, and Lorenzo Stefano Maffioli, “Radium-223 dichloride in clinical practice: a review,” European Journal of Nuclear Medicine and Molecular Imaging, 2016. View at Publisher · View at Google Scholar
  • Serena Pullini, Marco Andrea Signor, Martina Pancot, Chiara Zuiani, Massimo Bazzocchi, Sandro Fongione, and Rossano Girometti, “Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy,” European Journal of Radiology, vol. 85, no. 4, pp. 764–770, 2016. View at Publisher · View at Google Scholar
  • Giulio Nicita, Donata Villari, Simone Caroassai Grisanti, Michele Marzocco, Vincenzo Li Marzi, and Alberto Martini, “Minimally Invasive Transanal Repair of Rectourethral Fistulas,” European Urology, 2016. View at Publisher · View at Google Scholar
  • Tong Song, Xia Tian, Fan Kai, Jiang Ke, Zhai Wei, Li Jing-Song, Wang Jian-Jun, and Wang Si-Hua, “14-3-3ζ promotes lung cancer cell invasion by increasing the Snail protein expression through atypical protein kinase C (aPKC)/NF-κB signaling,” Experimental Cell Research, 2016. View at Publisher · View at Google Scholar
  • Archana Thakur, and Lawrence G. Lum, ““NextGen” Biologics: Bispecific Antibodies and Emerging Clinical Results,” Expert Opinion on Biological Therapy, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Athanasios Dellis, and Athanasios G. Papatsoris, “Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancer,” Expert Opinion on Investigational Drugs, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Sherry Zhao, Alfredo I. Urdaneta, and Mitchell S. Anscher, “The role of androgen deprivation therapy plus radiation therapy in patients with non-metastatic prostate cancer,” Expert Review of Anticancer Therapy, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Lev M. Berstein, “Insulinemia, heterogeneity of obesity and the risk of different types of endometrial cancer: existing evidence,” Expert Review of Endocrinology & Metabolism, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Maria Russo, Gian Luigi Russo, Maria Daglia, Pandima Devi Kasi, Sakthivel Ravi, Seyed Fazel Nabavi, and Seyed Mohammad Nabavi, “Understanding genistein in cancer: The “good” and the “bad” effects: A review,” Food Chemistry, vol. 196, pp. 589–600, 2016. View at Publisher · View at Google Scholar
  • Ken Batai, Adam B. Murphy, Larisa Nonn, and Rick A. Kittles, “Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans,” Frontiers In Immunology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Maria Ferraiuolo, Silvia Di Agostino, Giovanni Blandino, and Sabrina Strano, “Oncogenic Intra-p53 Family Member Interactions in Human Cancers,” Frontiers in Oncology, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Hans-Theo Schon, and Ralf Weiskirchen, “Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury,” Frontiers in Pharmacology, vol. 07, 2016. View at Publisher · View at Google Scholar
  • Kevin C McCammack, Steven S Raman, and Daniel JA Margolis, “Imaging of local recurrence in prostate cancer,” Future Oncology, 2016. View at Publisher · View at Google Scholar
  • Rohina Rubicz, Shanshan Zhao, Milan Geybels, Jonathan L. Wright, Suzanne Kolb, Brandy Klotzle, Marina Bibikova, Dean Troyer, Raymond Lance, Elaine A. Ostrander, Ziding Feng, Jian-Bing Fan, and Janet L. Stanford, “DNA methylation profiles in African American prostate cancer patients in relation to disease progression,” Genomics, 2016. View at Publisher · View at Google Scholar
  • Awatef Ben Jemaa, Yosra Bouraoui, Nawfel Ben Rais, Yassine Nouira, and Ridha Oueslati, “Cytokine profiling identifies an interaction of IL-6 and IL-1α to drive PSMA-PSA prostate clones,” Immunobiology, 2016. View at Publisher · View at Google Scholar
  • Benjamin A. Rybicki, Andrew Rundle, Oleksandr N. Kryvenko, Nicoleta Mitrache, Kieu C. Do, Michelle Jankowski, Dhananjay A. Chitale, Sheri Trudeau, Steven A. Belinsky, and Deliang Tang, “Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer,” International Journal of Cancer, vol. 138, no. 12, pp. 2884–2893, 2016. View at Publisher · View at Google Scholar
  • Takashi Mizowaki, Yoshiki Norihisa, Kenji Takayama, Itaru Ikeda, Haruo Inokuchi, Kiyonao Nakamura, Tomomi Kamba, Takahiro Inoue, Toshiyuki Kamoto, Osamu Ogawa, and Masahiro Hiraoka, “Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer,” International Journal of Clinical Oncology, 2016. View at Publisher · View at Google Scholar
  • K. Stingl Jankovic, T. Hudolin, Z. Kastelan, R. Zunec, and Z. Grubic, “The possible role of the tumour necrosis factor polymorphisms and human leucocyte antigens in the development of prostate cancer,” International Journal of Immunogenetics, 2016. View at Publisher · View at Google Scholar
  • Kaile Zhang, Shukui Zhou, Leilei Wang, Jianlong Wang, Qingsong Zou, Weixin Zhao, Qiang Fu, and Xiaolan Fang, “Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer,” International Journal of Molecular Sciences, vol. 17, no. 7, pp. 1163, 2016. View at Publisher · View at Google Scholar
  • Wei-Yu Chen, Kuo-Tai Hua, Wei-Jiunn Lee, Yung-Wei Lin, Yen-Nien Liu, Chi-Long Chen, Yu-Ching Wen, and Ming-Hsien Chien, “Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy,” International Journal of Molecular Sciences, vol. 17, no. 8, pp. 1194, 2016. View at Publisher · View at Google Scholar
  • Kin-Mang Lau, and Ka-Fai To, “Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer,” International Journal of Molecular Sciences, vol. 17, no. 9, pp. 1434, 2016. View at Publisher · View at Google Scholar
  • Tao Liu, and Qianxia Huang, “Biodegradable Brush-Type Copolymer Modified with Targeting Peptide as a Nanoscopic Platform for Targeting Drug Delivery to Treat Castration-Resistant Prostate Cancer,” International Journal of Pharmaceutics, 2016. View at Publisher · View at Google Scholar
  • William A. Sterling, Joseph Weiner, David Schreiber, Komal Mehta, and Jeffrey P. Weiss, “The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population,” International Urology and Nephrology, 2016. View at Publisher · View at Google Scholar
  • Belinda F. Morrison, William Aiken, Richard Mayhew, Yulit Gordon, and Marvin Reid, “Prostate Cancer Screening in Jamaica: Results of the Largest National Screening Clinic,” Journal of Cancer Epidemiology, vol. 2016, pp. 1–4, 2016. View at Publisher · View at Google Scholar
  • Joseph Kangmennaang, and Isaac Luginaah, “The Influences of Health Insurance and Access to Information on Prostate Cancer Screening among Men in Dominican Republic,” Journal of Cancer Epidemiology, vol. 2016, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Joseph Kangmennaang, Paul Mkandawire, and Isaac Luginaah, “What Prevents Men Aged 40–64 Years from Prostate Cancer Screening in Namibia?,” Journal of Cancer Epidemiology, vol. 2016, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Moran Benhar, Iart Luca Shytaj, Jonathan S. Stamler, and Andrea Savarino, “Dual targeting of the thioredoxin and glutathione systems in cancer and HIV,” Journal of Clinical Investigation, vol. 126, no. 5, pp. 1630–1639, 2016. View at Publisher · View at Google Scholar
  • Daniel S. W. Tan, Tony S. K. Mok, and Timothy R. Rebbeck, “Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography,” Journal Of Clinical Oncology, vol. 34, no. 1, pp. 91–+, 2016. View at Publisher · View at Google Scholar
  • Charlotte Naslund-Koch, Borge G. Nordestgaard, and Stig E. Bojesen, “Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2(star)1100delC Heterozygotes Estimated From the Copenhagen General Population S,” Journal Of Clinical Oncology, vol. 34, no. 11, pp. 1208–+, 2016. View at Publisher · View at Google Scholar
  • Mahdi Bakhshabadi, Mahdi Ghorbani, Mohsen Khosroabadi, Courtney Knaup, and Ali S. Meigooni, “A comparison study on various low energy sources in interstitial prostate brachytherapy,” Journal Of Contemporary Brachytherapy, vol. 8, no. 1, pp. 74–81, 2016. View at Publisher · View at Google Scholar
  • Udensi K. Udensi, and Paul B. Tchounwou, “Oxidative stress in prostate hyperplasia and carcinogenesis,” Journal of Experimental & Clinical Cancer Research, vol. 35, no. 1, 2016. View at Publisher · View at Google Scholar
  • Harsh K. Agarwal, Francesca V. Mertan, Sandeep Sankineni, Marcelino Bernardo, Julien Senegas, Jochen Keupp, Dagane Daar, Maria Merino, Bradford J. Wood, Peter A. Pinto, Peter L. Choyke, and Baris Turkbey, “Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone,” Journal of Magnetic Resonance Imaging, 2016. View at Publisher · View at Google Scholar
  • Mathias Tesson, Colin Rae, Colin Nixon, John W. Babich, and Robert J. Mairs, “ Preliminary evaluation of prostate-targeted radiotherapy using 131 I-MIP-1095 in combination with radiosensitising chemotherapeutic drugs ,” Journal of Pharmacy and Pharmacology, 2016. View at Publisher · View at Google Scholar
  • Jonathan G. Sham, Morgan K. Richards, Y. David Seo, Venu G. Pillarisetty, Raymond S. Yeung, and James O. Park, “Efficacy and cost of robotic hepatectomy: is the robot cost-prohibitive?,” Journal of Robotic Surgery, 2016. View at Publisher · View at Google Scholar
  • Anup Kumar, Sarvesh Tandon, Srinivas Samavedi, Vladimir Mouraviev, Anthony S. Bates, and Vipul R. Patel, “Current status of various neurovascular bundle-sparing techniques in robot-assisted radical prostatectomy,” Journal of Robotic Surgery, 2016. View at Publisher · View at Google Scholar
  • Ji Y. Buethe, Salim Abboud, Kristie Brock, Greg Nizialek, Rod Rezaee, Jay Wasman, Jonathan Frankel, and Dean A. Nakamoto, “Percutaneous CT-Guided Cryoablation of the Salivary Glands in a Porcine Model,” Journal of Vascular and Interventional Radiology, 2016. View at Publisher · View at Google Scholar
  • Ruijie Yang, Nan Zhao, Anyan Liao, Hao Wang, and Ang Qu, “Dosimetric and radiobiological comparison of volumetric modulated arc therapy, high-dose rate brachytherapy, and low-dose rate permanent seeds implant for localized prostate cancer,” Medical Dosimetry, 2016. View at Publisher · View at Google Scholar
  • Xiaohui Xu, Xinguang Chen, Hui Hu, Amy B. Dailey, and Folakemi T. Odedina, “Current Opinion in the Role of Testosterone in the Development of Prostate Cancer: A Dynamic Model,” Medical Hypotheses, 2016. View at Publisher · View at Google Scholar
  • C. F. Chang, J. Yang, X. F. Li, W. M. Zhao, S. S. Chen, G. P. Wang, and C. S. Xu, “SPINK3: A novel growth factor that promotes rat liver regeneration,” Molecular Biology, vol. 50, no. 3, pp. 398–404, 2016. View at Publisher · View at Google Scholar
  • Javier C. Angulo, Jose I. López, and Santiago Ropero, “DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects,” Molecular Diagnosis & Therapy, 2016. View at Publisher · View at Google Scholar
  • A Hinney, M Kesselmeier, S Jall, A-L Volckmar, M Föcker, J Antel, Vesna Boraska Perica, Christopher S Franklin, James A B Floyd, Laura M Thornton, Laura M Huckins, Lorraine Southam, N William Rayner, Ioanna Tachmazidou, Kelly L Klump, Janet Treasure, Cathryn M Lewis, Ulrike Schmidt, Federica Tozzi, Kirsty iezebrink, Johannes Hebebrand, Philip Gorwood, Roger A H Adan, Martien J H Kas, Angela Favaro, Paolo Santonastaso, Fernando Fernández-Aranda, Monica Gratacos, Filip Rybakowski, Monika Dmitrzak-Weglarz, Jaakko Kaprio, Anna Keski-Rahkonen, Anu Raevuori-Helkamaa, Eric F Van Furth, Margarita C T Slof-Op't Landt, James I Hudson, Ted Reichborn-Kjennerud, Gun Peggy S Knudsen, Palmiero Monteleone, Allan S Kaplan, Andreas Karwautz, Hakon Hakonarson, Wade H Berrettini, Yiran Guo, Dong Li, Nicholas J Schork, Gen Komaki, Tetsuya Ando, Hidetoshi Inoko, Tõnu Esko, Krista Fischer, Katrin Männik, Andres Metspalu, Jessica H Baker, Roger D Cone, Jennifer Dackor, Janiece E DeSocio, Christopher E Hilliard, Julie K O'Toole, Jacques Pantel, Jin P Szatkiewicz, Chrysecolla Taico, Stephanie Zerwas, Sara E Trace, Oliver S P Davis, Sietske Helder, Katharina Bühren, Roland Burghardt, Martina de Zwaan, Karin Egberts, Stefan Ehrlich, Beate Herpertz-Dahlmann, Wolfgang Herzog, Hartmut Imgart, André Scherag, Susann Scherag, Stephan Zipfel, Claudette Boni, Nicolas Ramoz, Audrey Versini, Marek K Brandys, Unna N Danner, Carolien de Kove, Judith Hendriks, Bobby P C Koeleman, Roel A Ophoff, Eric Strengman, Annemarie A van Elburg, Alice Bruson, Maurizio Clementi, Daniela Degortes, Monica Forzan, Elena Tenconi, Elisa Docampo, Geòrgia Escaramí, Susana Jiménez-Murcia, Jolanta Lissowska, Andrzej Rajewski, Neonila Szeszenia-Dabrowska, Agnieszka Slopien, Joanna Hauser, Leila Karhunen, Ingrid Meulenbelt, P Eline Slagboom, Alfonso Tortorella, Mario Maj, George Dedoussis, Dimitris Dikeos, Fragiskos Gonidakis, Konstantinos Tziouvas, Artemis Tsitsika, Hana Papezova, Lenka Slachtova, Debora Martaskova, James L Kennedy, Robert D Levitan, Zeynep Yilmaz, Julia Huemer, Doris Koubek, Elisabeth Merl, Gudrun Wagner, Paul Lichtenstein, Gerome Breen, Sarah Cohen-Woods, Anne Farmer, Peter McGuffin, Sven Cichon, Ina Giegling, Stefan Herms, Dan Rujescu, Stefan Schreiber, H-Erich Wichmann, Christian Dina, Rob Sladek, Giovanni Gambaro, Nicole Soranzo, Antonio Julia, Sara Marsal, Raquel Rabionet, Valerie Gaborieau, Danielle M Dick, Aarno Palotie, Samuli Ripatti, Elisabeth Widén, Ole A Andreassen, Thomas Espeseth, Astri Lundervold, Ivar Reinvang, Vidar M Steen, Stephanie Le Hellard, Morten Mattingsdal, Ioanna Ntalla, Vladimir Bencko, Lenka Foretova, Vladimir Janout, Marie Navratilova, Steven Gallinger, Dalila Pinto, Stephen W Scherer, Harald Aschauer, Laura Carlberg, Alexandra Schosser, Lars Alfredsson, Bo Ding, Lars Klareskog, Leonid Padyukov, Chris Finan, Gursharan Kalsi, Marion Roberts, Darren W Logan, Leena Peltonen, Graham R S Ritchie, Jeff C Barrett, Xavier Estivill, Anke Hinney, Patrick F Sullivan, David A Collier, Eleftheria Zeggini, Cynthia M Bulik, Carl A Anderson, Jeffrey C Barrett, James A B Floyd, Christopher S Franklin, Ralph McGinnis, Nicole Soranzo, Eleftheria Zeggini, Jennifer Sambrook, Jonathan Stephens, Willem H Ouwehand, Wendy L McArdle, Susan M Ring, David P Strachan, Graeme Alexander, Cynthia M Bulik, David A Collier, Peter J Conlon, Anna Dominiczak, Audrey Duncanson, Adrian Hill, Cordelia Langford, Graham Lord, Alexander P Maxwell, Linda Morgan, Leena Peltonen, Richard N Sandford, Neil Sheerin, Frederik O Vannberg, Hannah Blackburn, Wei-Min Chen, Sarah Edkins, Mathew Gillman, Emma Gray, Sarah E Hunt, Suna Nengut-Gumuscu, Simon Potter, Stephen S Rich, Douglas Simpkin, Pamela Whittaker, I M Heid, T W Winkler, P de Bakker, U Bültmann, M Geleijnse, P V Harst, G Koppelman, J G Rosmalen, L van Rossum, H Smidt, M A Swertz, R P Stolk, B Alizadeh, R de Boer, H M Boezen, M Bruinenberg, L Franke, P van der Harst, H Hillege, M View at Publisher · View at Google Scholar
  • Long-Bin Cao, Sha Zeng, and Wei Zhao, “Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers,” Nanoscale Research Letters, vol. 11, no. 1, 2016. View at Publisher · View at Google Scholar
  • Tao Zhang, Chieh Tseng, Yan Zhang, Olga Sirin, Paul G. Corn, Elsa M. Li-Ning-Tapia, Patricia Troncoso, John Davis, Curtis Pettaway, John Ward, Marsha L. Frazier, Christopher Logothetis, and Mikhail G. Kolonin, “CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment,” Nature Communications, vol. 7, pp. 11674, 2016. View at Publisher · View at Google Scholar
  • Kathleen F. McGinley, Kae Jack Tay, and Judd W. Moul, “Prostate cancer in men of African origin,” Nature Reviews Urology, vol. 13, no. 2, pp. 99–107, 2016. View at Publisher · View at Google Scholar
  • Terrence M. Vance, Ying Wang, L. Joseph Su, Elizabeth T. H. Fontham, Susan E. Steck, Lenore Arab, Jeannette T. Bensen, James L. Mohler, Ming-Hui Chen, and Ock K. Chun, “Dietary total antioxidant capacity is inversely associated with prostate cancer aggressiveness in a population-based study,” Nutrition and Cancer, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Zhenzhen Zhang, Mark Garzotto, Tomasz M. Beer, Philippe Thuillier, Stephen Lieberman, Motomi Mori, Wesley A. Stoller, Paige E. Farris, and Jackilen Shannon, “ Effects of ω -3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial ,” Nutrition and Cancer, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Joanna Huszno, Magdalena Budryk, Zofia Kolosza, Karolina Tecza, Jolanta Pamula Pilat, Elzbieta Nowara, and Ewa Grzybowska, “A Comparison between CHEK2*1100deIC/I157T Mutation Carrier and Noncarrier Breast Cancer Patients: A Clinicopathological Analysis,” Oncology, vol. 90, no. 4, pp. 193–198, 2016. View at Publisher · View at Google Scholar
  • Yang Meng, Yan-Biao Liao, Peng Xu, Wu-Ran Wei, and Jia Wang, “Statin use and mortality of patients with prostate cancer: a meta-analysis,” Oncotargets And Therapy, vol. 9, pp. 1689–1696, 2016. View at Publisher · View at Google Scholar
  • Marco Schwarz, and Silvia Molinelli, “What can particle therapy add to the treatment of prostate cancer?,” Physica Medica, 2016. View at Publisher · View at Google Scholar
  • Pietro Mancosu, Stefania Clemente, Valeria Landoni, Ruggero Ruggieri, Filippo Alongi, Marta Scorsetti, and Michele Stasi, “SBRT for prostate cancer: Challenges and features from a physicist prospective,” Physica Medica-European Journal Of Medical Physics, vol. 32, no. 3, pp. 479–484, 2016. View at Publisher · View at Google Scholar
  • Yue-Hong Shen, Fei Yang, Hua Wang, Zhi-Jian Cai, Yi-Peng Xu, An Zhao, Ying Su, Gu Zhang, and Shao-Xing Zhu, “Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice,” Plos One, vol. 11, no. 1, 2016. View at Publisher · View at Google Scholar
  • Peter C. Elwood, Gareth Morgan, Janet E. Pickering, Julieta Galante, Alison L. Weightman, Delyth Morris, Mark Kelson, and Sunil Dolwani, “Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies,” Plos One, vol. 11, no. 4, 2016. View at Publisher · View at Google Scholar